BI 1021958
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers
CompletedNCT01541488
Start: 2012-02-29Updated: 2013-10-31
Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers
CompletedNCT02202512
Start: 2014-09-30End: 2014-12-31Updated: 2014-12-24